ONE-WAYOngoing theme · still written in the latest filings

Immune Cell Culture Platform Based on Glycan Modification and Metabolic Control

A technology platform that uses glycan modification and metabolic control to enhance the culture and function of immune cells, with the aim of applying it to next-generation immunotherapies such as 2-DG lymphocytes and CAR-T cells.

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2019 →Still being written about.

Directionhelps1 helps · 0 hurts · 0 flat